沙特阿拉伯麦加地区沙特献血者中B19微小病毒IgG血清阳性率
SEROPREVALENCE OF ERYTHROVIRUS B19 IgG AMONG SAUDI BLOOD DONORS IN MAKKAH, SAUDI ARABIA.
作者信息
Johargy Ayman K
机构信息
Department of Microbiology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
出版信息
J Family Community Med. 2009 Sep;16(3):111-4.
Abstract
OBJECTIVES
To determine the seroprevalence of immunoglobulin G (IgG) to erythrovirus B19 in Saudi blood donors in Makkah. Saudi Arabia.
SUBJECTS AND METHODS
A total of 578 blood (serum) samples were tested for erythrovirus B19-specific-IgG antibody among Saudi blood donors in Makkah. Saudi Arabia.
RESULTS
Erythrovirus B19-specific-IgG antibodies were detected in 441/578 (76.3%) of Saudi blood donors of different age groups.
CONCLUSION
This study indicated that 76.3% of Saudi blood donors in Makkah city, Saudi Arabia, had been exposed to erythrovirus B19. This result is in accordance with previous studies performed in other countries.
摘要
目的
确定沙特阿拉伯麦加地区献血者中抗B19微小病毒免疫球蛋白G（IgG）的血清流行率。
对象与方法
对沙特阿拉伯麦加地区的沙特献血者的578份血液（血清）样本进行了B19微小病毒特异性IgG抗体检测。
结果
在不同年龄组的578名沙特献血者中，有441人（76.3%）检测到B19微小病毒特异性IgG抗体。
结论
本研究表明，沙特阿拉伯麦加市76.3%的沙特献血者曾接触过B19微小病毒。这一结果与其他国家此前的研究一致。
相似文献
1
SEROPREVALENCE OF ERYTHROVIRUS B19 IgG AMONG SAUDI BLOOD DONORS IN MAKKAH, SAUDI ARABIA.沙特阿拉伯麦加地区沙特献血者中B19微小病毒IgG血清阳性率
J Family Community Med. 2009 Sep;16(3):111-4.
2
Seroprevalence of erythrovirus B19 in Saudi pregnant women.沙特孕妇中B19微小病毒的血清流行率。
J Family Community Med. 2016 May-Aug;23(2):105-8. doi: 10.4103/2230-8229.181010.
3
Seroprevalence of erythrovirus B19 IgG antibody among paediatric patients in Makkah and Jeddah, Kingdom of Saudi Arabia.
Med Princ Pract. 2009;18(4):339-41. doi: 10.1159/000215736. Epub 2009 Jun 2.
4
Prevalence of antibodies to human parvovirus b19 in saudi women of childbearing age in makkah.麦加育龄沙特女性中抗人细小病毒b19抗体的流行情况
J Family Community Med. 2007 Jan;14(1):15-7.
5
Seroprevalence of Asymptomatic Dengue Virus Infection and Its Antibodies Among Healthy/Eligible Saudi Blood Donors: Findings From Holy Makkah City.沙特健康/合格献血者中无症状登革病毒感染及其抗体的血清流行率：来自圣城麦加的研究结果
Virology (Auckl). 2017 Feb 24;8:1-5. doi: 10.1177/1178122X17691261. eCollection 2017.
6
High Seroprevalence of SARS-CoV-2 IgG and RNA among Asymptomatic Blood Donors in Makkah Region, Saudi Arabia.沙特阿拉伯麦加地区无症状献血者中新冠病毒2型免疫球蛋白G和核糖核酸的高血清阳性率
Vaccines (Basel). 2022 Aug 8;10(8):1279. doi: 10.3390/vaccines10081279.
7
Anti hepatitis E virus seropositivity in a group of male blood donors in Makkah, Saudi Arabia.沙特阿拉伯麦加一组男性献血者中抗戊型肝炎病毒血清阳性情况。
J Pak Med Assoc. 2013 Feb;63(2):185-9.
8
Seroepidemiological survey on Rift Valley fever among small ruminants and their close human contacts in Makkah, Saudi Arabia, in 2011.2011年沙特阿拉伯麦加小反刍动物及其密切接触人群中裂谷热的血清流行病学调查。
Rev Sci Tech. 2014 Dec;33(3):903-15. doi: 10.20506/rst.33.3.2328.
9
Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in North Indian voluntary blood donors.B19 IgG酶联免疫吸附测定标准化以研究印度北部无偿献血者中细小病毒B19的血清流行病学。
Asian J Transfus Sci. 2010 Jul;4(2):86-90. doi: 10.4103/0973-6247.67022.
10
Seropositivity of Chlamydia trachomatis among saudi pregnant women in makkah.麦加沙特孕妇沙眼衣原体血清阳性情况
J Family Community Med. 2006 May;13(2):61-4.
引用本文的文献
1
Ensuring Transfusion Safety: Screening Blood Donors for Human Parvovirus B19.确保输血安全：筛查献血者是否感染人细小病毒B19
Cureus. 2024 Aug 21;16(8):e67359. doi: 10.7759/cureus.67359. eCollection 2024 Aug.
2
Molecular and serological markers of human parvovirus B19 infection in blood donors: A systematic review and meta-analysis.献血者中人类细小病毒B19感染的分子和血清学标志物：一项系统评价和荟萃分析。
Asian J Transfus Sci. 2021 Jul-Dec;15(2):212-222. doi: 10.4103/ajts.ajts_185_20. Epub 2021 Nov 1.
3
Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar.在卡塔尔居住的不同国籍献血者中细小病毒（B19V）的流行情况及系统进化分析。
Viruses. 2021 Mar 24;13(4):540. doi: 10.3390/v13040540.
4
Seroprevalence of erythrovirus B19 in Saudi pregnant women.沙特孕妇中B19微小病毒的血清流行率。
J Family Community Med. 2016 May-Aug;23(2):105-8. doi: 10.4103/2230-8229.181010.
本文引用的文献
1
Genetic variants of parvovirus B19 identified in the United Kingdom: implications for diagnostic testing.在英国发现的细小病毒B19的基因变异：对诊断检测的影响。
J Clin Virol. 2006 Jun;36(2):152-5. doi: 10.1016/j.jcv.2006.01.011. Epub 2006 Mar 29.
2
Parvovirus B19: a cause for aplastic crisis and hemophagocytic lymphohistiocytosis.细小病毒B19：再生障碍性危象和噬血细胞性淋巴组织细胞增生症的一个病因。
Pediatr Blood Cancer. 2006 Nov;47(6):861. doi: 10.1002/pbc.20807.
3
Novel parvovirus and related variant in human plasma.人血浆中的新型细小病毒及相关变体。
Emerg Infect Dis. 2006 Jan;12(1):151-4. doi: 10.3201/eid1201.050916.
4
Identification and characterization of persistent human erythrovirus infection in blood donor samples.献血者样本中持续性人红细胞病毒感染的鉴定与特征分析。
J Virol. 2004 Nov;78(22):12169-78. doi: 10.1128/JVI.78.22.12169-12178.2004.
5
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors.意大利献血者中针对细小病毒B19构象和线性衣壳抗原的IgG血清阳性率。
Epidemiol Infect. 2004 Oct;132(5):857-62. doi: 10.1017/s0950268804002389.
6
Parvovirus B19.细小病毒B19
N Engl J Med. 2004 Feb 5;350(6):586-97. doi: 10.1056/NEJMra030840.
7
Seroprevalence of human parvovirus B19 infection in an urban population in Malaysia.马来西亚城市人口中人类细小病毒B19感染的血清流行率。
Med J Malaysia. 2002 Mar;57(1):97-103.
8
Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins.比利时健康献血者中人类细小病毒B19 DNA的流行率及其与针对病毒结构和非结构蛋白的特异性抗体的相关性
Vox Sang. 2003 May;84(4):300-7. doi: 10.1046/j.1423-0410.2003.00299.x.
9
Neurological manifestations of human parvovirus B19 infection.人细小病毒B19感染的神经学表现
Rev Med Virol. 2003 May-Jun;13(3):185-99. doi: 10.1002/rmv.388.
10
Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant.一名婴儿感染细小病毒B19后出现的活动性、暴发性、致死性心肌炎。
Clin Infect Dis. 2002 Nov 1;35(9):1027-31. doi: 10.1086/342574. Epub 2002 Oct 11.
Zotero 插件